Glaxo Acetaminophen Efficacy Studies Fill FDA's 1,000-MG Dose Data Gaps
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline generated clinical data supporting the greater pain-relief efficacy of 1,000 mg of acetaminophen over 500-mg and 650-mg doses, urging FDA to maintain OTC status for the high dose.